Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

BSEM

BioStem Technologies Inc

3.68

Aug 20 • 3:59 PM ET +0.34 (10.01%)

3.61

Aftermarket • 7:44 PM ET -0.07 (-1.90%)

Healthcare Biotechnology USA Micro NASD

Scroll to Statements

Index	-
Market Cap	65.62M
Enterprise Value	59.88M
Income	-28.29M
Sales	34.59M
Book/sh	1.55
Cash/sh	0.39
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Oct 17, 2003

P/E	-
Forward P/E	-
PEG	-
P/S	1.90
P/B	2.37
P/C	9.43
P/FCF	-
EV/EBITDA	-
EV/Sales	1.73
Quick Ratio	0.76
Current Ratio	0.98
Debt/Eq	0.04
LT Debt/Eq	0.00
Option/Short	No / Yes

EPS (ttm)	-1.68
EPS next Y	-0.25
EPS next Q	-0.46
EPS this Y	-400.00%
EPS next Y	87.18%
EPS next 5Y	-
EPS past 3/5Y	14.56% -7.36%
Sales past 3/5Y	90.44% 81.44%
EPS Y/Y TTM	-204.26%
Sales Y/Y TTM	-88.74%
EPS Q/Q	-1431.95%
Sales Q/Q	-83.98%
Earnings	Aug 12 AMC
EPS/Sales Surpr.	-4.00% 24.36%

Insider Own	27.17%
Insider Trans	0.00%
Inst Own	-
Inst Trans	0.00%
ROA	-35.05%
ROE	-74.74%
ROIC	-102.44%
Gross Margin	76.08%
Oper. Margin	-67.47%
Profit Margin	-81.80%
SMA20	5.91%
SMA50	2.25%
SMA200	-17.78%
Trades

Shs Outstand	17.82M
Shs Float	12.99M
Short Float	3.02%
Short Ratio	5.65
Short Interest	0.39M
52W High	8.40 -56.19%
52W Low	2.25 63.48%
Volatility	11.78% 14.99%
ATR (14)	0.50
RSI (14)	52.84
Beta	0.25
Rel Volume	2.24
Avg Volume	69.36K
Volume	155,038

Perf Week	18.71%
Perf Month	-6.36%
Perf Quarter	-7.88%
Perf Half Y	-40.84%
Perf YTD	-3.41%
Perf Year	-40.16%
Perf 3Y	156.00%
Perf 5Y	240.74%
Perf 10Y	-71.69%
Recom	1.00
Target Price	7.00
Prev Close	3.35
Price	3.68
Change %	10.01%

Aug-18-26 10:00AM	Sidoti Events, LLC's August Micro-Cap Virtual Conference (ACCESSWIRE) +5.00%
Aug-13-26 01:03AM	BioStem Technologies Inc (BSEM) (Q2 2026) Earnings Call Highlights: Revenue Surges to $7. ... (GuruFocus.com) -18.42%
Aug-11-26 09:25AM	BioStem Technologies Inc (BSEM) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Jun-09-26 10:50AM	BioStem Technologies Expands Board with Three Appointments as Nasdaq Uplisting Remains a Key Objective (BSEM) (InvestorsHub)

BioStem Technologies, Inc. engages in the provision of regenerative medicine and anti-aging solutions. It offers pre-treatment assessment, cell therapies, anti-aging, and wellness compounds. The company was founded by Andrew Smith Van Vurst, Henry W. Van Vurst IV, and Jason Matuszewski on April 29, 1939 and is headquartered in Pompano Beach, FL.

CEOMr. Jason V. Matuszewski

Chief Financial OfficerMr. Brandon Poe

COO & DirectorMr. Andrew Van Vurst CTBS

Chief Accounting OfficerMr. Michael A. Fortunato C.P.A.

Vice President of Corporate Finance & StrategyMr. Noah Agron

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
POE BRANDON	Chief Financial Officer	Aug 11 '26	Option Exercise	0.00	10,634	0	56,368	Aug 20 07:30 PM
FORTUNATO MICHAEL A	Chief Accounting Officer	Aug 09 '26	Option Exercise	0.00	970	0	64,430	Aug 20 07:30 PM

BSEM

BioStem Technologies Inc

Upgrade your Finviz experience